CA-125 serum concentrations during the menstrual cycle
- 1 August 1988
- journal article
- Published by Elsevier in Fertility and Sterility
- Vol. 50 (2), 223-227
- https://doi.org/10.1016/s0015-0282(16)60063-8
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Elevated levels of CA-125 in serum of patients suffering from ovarian hyperstimulation syndromeFertility and Sterility, 1987
- Elevation of CA 125 in patients with benign and malignant ascitesCancer, 1987
- CA 125 antigen in human amniotic fluid and fetal membranesAmerican Journal of Obstetrics and Gynecology, 1986
- Elevated serum concentrations of CA-125 in patients with advanced endometriosisFertility and Sterility, 1986
- Use of the CA 125 antigen in diagnosis and monitoring of ovarian carcinomaEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 1985
- Ca 125 and Ca 19–9: two cancer‐associated sialylsaccharide antigens on a mucus glycoprotein from human milkEuropean Journal of Biochemistry, 1985
- Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigenAmerican Journal of Obstetrics and Gynecology, 1984
- Tissue Distribution of a Coelomic- Epithelium-Related Antigen Recognized by the Monoclonal Antibody OC125International Journal of Gynecological Pathology, 1983
- Measurement of Serum LH, FSH, Estradiol and Progesterone in Disorders of the Human Menstrual Cycle: The Inadequate Luteal PhaseJournal of Clinical Endocrinology & Metabolism, 1974
- The Short Luteal Phase12Journal of Clinical Endocrinology & Metabolism, 1970